Johnson & Johnson (JNJ) Tops Q3 EPS by 23c, Beats on Revenue
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $271.11 -1.5%
EPS Growth %: +3.6%
Financial Fact:
Research and development expense: 2.18B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +3.6%
Financial Fact:
Research and development expense: 2.18B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q3 EPS of $2.42, $0.23 better than the analyst estimate of $2.19. Revenue for the quarter came in at $22.5 billion versus the consensus estimate of $22.17 billion.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bessent: We Make A Market Buying Older Bonds
- Tenable to integrate Anthropic's Claude into its security platform
- Jefferies on MP Materials (MP): 'Magnet Ramp Remains on Track'
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
